MONTREAL, Nov. 14 /CNW Telbec/ - Biophage Pharma Inc. (TSX: BUG.V), a high potential, revenue driven biotechnology company focused on the development of an integrated approach for the prevention and control of bacterial infections, announced today its financial results and review of operating highlights for the year ended November 30, 2007.
